Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
Davenport
Andrew
A
UCL Center for Nephrology, University College London Medical School, Royal Free Campus, London, UK. Andrew.davenport@royalfree.nhs.uk
D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology*; D001323:Autoantibodies / Q000096:biosynthesis*; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D008297:Male; D010978:Platelet Factor 4 / Q000276:immunology*; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology* / Q000628:therapy
D000925:Anticoagulants; D001323:Autoantibodies; D010978:Platelet Factor 4; D006493:Heparin